CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 11.25
+0.42 (3.73%)
Jul 9, 2025, 4:35 PM GMT+1
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 4.50 million as of July 9, 2025. Its market cap has increased by 883.67% in one year.
Market Cap
4.50M
Enterprise Value
3.21M
Revenue
25.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
11.25
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 4.50M, a decrease of -84.08%. That is a compound annual growth rate of -9.07%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.28B |
| GSK plc | 56.46B |
| Haleon | 33.36B |
| Smith & Nephew | 9.70B |
| ConvaTec Group | 5.40B |
| Hikma Pharmaceuticals | 4.37B |
| HUTCHMED (China) | 1.93B |
| Oxford Nanopore Technologies | 1.42B |